FDA Preemption Policy Gets First Appeals Court Test With Zoloft, Paxil Cases

A federal appellate court will take up the issue of whether FDA approved labeling preempts state litigation claiming companies failed to warn of a product's risks, following years of conflicting rulings from district courts